Erik A. Jensen

4.5k total citations · 1 hit paper
88 papers, 2.7k citations indexed

About

Erik A. Jensen is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Erik A. Jensen has authored 88 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Pulmonary and Respiratory Medicine, 48 papers in Surgery and 27 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Erik A. Jensen's work include Neonatal Respiratory Health Research (79 papers), Congenital Diaphragmatic Hernia Studies (47 papers) and Infant Development and Preterm Care (20 papers). Erik A. Jensen is often cited by papers focused on Neonatal Respiratory Health Research (79 papers), Congenital Diaphragmatic Hernia Studies (47 papers) and Infant Development and Preterm Care (20 papers). Erik A. Jensen collaborates with scholars based in United States, Canada and China. Erik A. Jensen's co-authors include Barbara Schmidt, Haresh Kirpalani, Sara B. DeMauro, Kevin Dysart, Nicolas A. Bamat, Scott A. Lorch, Matthew M. Laughon, Eric C. Eichenwald, Scott A. McDonald and Andrea Duncan and has published in prestigious journals such as JAMA, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Erik A. Jensen

78 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach

2019 630 citations Erik A. Jensen, Kevin Dysart et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers

Erik A. Jensen

PRM

SURGE

PPCH

EAS

Jeffrey S. Gerdes United States

Richard Plavka Czechia

Eduardo Bancalari United States

Wes Onland Netherlands

Roland Hentschel Germany

James A. Thorp United States

Helmut Hummler Germany

Craig A. Nankervis United States

Sergio Golombek United States

Amish Jain Canada

Jeffrey S. Gerdes United States

Erik A. Jensen

1.6k ×0.7

PRM

727 ×0.5

SURGE

806 ×1.2

PPCH

410 ×0.8

EAS

177 ×0.6

Citations per year, relative to Erik A. Jensen Erik A. Jensen (= 1×) peers Jeffrey S. Gerdes

Countries citing papers authored by Erik A. Jensen

Since Specialization

Citations

This map shows the geographic impact of Erik A. Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik A. Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik A. Jensen more than expected).

Fields of papers citing papers by Erik A. Jensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik A. Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik A. Jensen. The network helps show where Erik A. Jensen may publish in the future.

Co-authorship network of co-authors of Erik A. Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of Erik A. Jensen. A scholar is included among the top collaborators of Erik A. Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik A. Jensen. Erik A. Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vega, Tomás, Erik A. Jensen, Catherine M. Avitabile, et al.. (2025). Pulmonary vasodilator use in very preterm infants in United States children’s hospitals. Journal of Perinatology. 45(10). 1382–1388. 1 indexed citations

DeMauro, Sara B., Erik A. Jensen, Molly Passarella, et al.. (2025). Oxygen Saturation Targeting for Infants with Bronchopulmonary Dysplasia: A Pilot Randomized Trial. Annals of the American Thoracic Society. 22(4). 560–569. 2 indexed citations

Xu, He N., et al.. (2024). Use of Optical Redox Imaging to Quantify Alveolar Macrophage Redox State in Infants: Proof of Concept Experiments in a Murine Model and Human Tracheal Aspirates Samples. Antioxidants. 13(5). 546–546.

Nelin, Timothy D., Nancy Yang, Scott A. Lorch, et al.. (2024). Associations of PM_2.5 exposure with emergency department visits and readmissions among preterm infants with bronchopulmonary dysplasia. Pediatric Pulmonology. 59(11). 2947–2955.

DeMauro, Sara B., et al.. (2024). Environmental Determinants of Post-Discharge Acute Respiratory Illness among Preterm Infants with Bronchopulmonary Dysplasia. International Journal of Environmental Research and Public Health. 21(5). 648–648. 2 indexed citations

Aleem, Samia, T. Barbara, Marie G. Gantz, et al.. (2024). The association of the room air challenge with long-term outcomes in extremely preterm infants. Journal of Perinatology. 44(9). 1300–1306.

Nelin, Timothy D., Erik A. Jensen, Sara B. DeMauro, et al.. (2024). Association of furosemide versus chlorothiazide exposures with serum sodium, potassium, and chloride among infants with bronchopulmonary dysplasia. Journal of Perinatology. 45(3). 312–318.

Bancalari, Eduardo, Sanne J. Gordijn, Rosemary D. Higgins, et al.. (2023). Towards a harmonized bronchopulmonary dysplasia definition: a study protocol for an international Delphi procedure. BMJ Paediatrics Open. 7(1). e002112–e002112. 6 indexed citations

Wright, Clyde J., David J. McCulley, Souvik Mitra, & Erik A. Jensen. (2023). Acetaminophen for the patent ductus arteriosus: has safety been adequately demonstrated?. Journal of Perinatology. 43(10). 1230–1237. 7 indexed citations

10.

Jensen, Erik A., Matthew M. Laughon, Sara B. DeMauro, et al.. (2022). Contributions of the NICHD neonatal research network to the diagnosis, prevention, and treatment of bronchopulmonary dysplasia. Seminars in Perinatology. 46(7). 151638–151638. 12 indexed citations

11.

Nelin, Timothy D., Scott A. Lorch, Erik A. Jensen, et al.. (2021). The association between diuretic class exposures and enteral electrolyte use in infants developing grade 2 or 3 bronchopulmonary dysplasia in United States children’s hospitals. Journal of Perinatology. 41(4). 779–785. 7 indexed citations

12.

Napolitano, Natalie, Tracey Roberts, Amanda Nickel, et al.. (2021). Performance Evaluation of Nasal Prong Interface for CPAP Delivery on a Critical Care Ventilator: A Bench Experiment. Respiratory Care. 66(10). 1514–1520. 1 indexed citations

13.

Jensen, Erik A., Ammie M. White, Yan Wang, et al.. (2020). Characterization of Disease Phenotype in Very Preterm Infants with Severe Bronchopulmonary Dysplasia. American Journal of Respiratory and Critical Care Medicine. 201(11). 1398–1406. 91 indexed citations

14.

Jensen, Erik A., Robin S. Roberts, & Barbara Schmidt. (2020). Drugs to Prevent Bronchopulmonary Dysplasia: Effect of Baseline Risk on the Number Needed to Treat. The Journal of Pediatrics. 222. 244–247. 13 indexed citations

15.

Jensen, Erik A., Kevin Dysart, Marie G. Gantz, et al.. (2019). The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach. American Journal of Respiratory and Critical Care Medicine. 200(6). 751–759. 630 indexed citations breakdown →

16.

Bamat, Nicolas A., Haresh Kirpalani, Chris Feudtner, et al.. (2019). Medication use in infants with severe bronchopulmonary dysplasia admitted to United States children’s hospitals. Journal of Perinatology. 39(9). 1291–1299. 43 indexed citations

17.

Liu, Yufeng, Michela Perego, Qiang Xiao, et al.. (2019). Lactoferrin-induced myeloid-derived suppressor cell therapy attenuates pathologic inflammatory conditions in newborn mice. Journal of Clinical Investigation. 129(10). 4261–4275. 62 indexed citations

18.

He, Yumei, Xing Li, Michela Perego, et al.. (2018). Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation. Nature Medicine. 24(2). 224–231. 157 indexed citations

19.

Jensen, Erik A., Elizabeth E. Foglia, & Barbara Schmidt. (2018). Association between prophylactic indomethacin and death or bronchopulmonary dysplasia: A systematic review and meta-analysis of observational studies. Seminars in Perinatology. 42(4). 228–234. 21 indexed citations

20.

Bamat, Nicolas A., Sarvin Ghavam, Yumei Liu, et al.. (2015). Reliability of a Noninvasive Measure of V/Q Mismatch for Bronchopulmonary Dysplasia. Annals of the American Thoracic Society. 12(5). 727–733. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact